Professional Overview
Nergis Sertel is a seasoned clinical operations professional with extensive experience in the pharmaceutical industry. As a Senior Clinical Operations Lead at Roche, she leverages her expertise in clinical trial management, site activation, and feasibility assessment to drive operational excellence. Her industry focus spans clinical research, project management, and team leadership.
Experience Summary
Current Role
Nergis Sertel currently serves as a Senior Clinical Operations Lead at Roche, a role she has held since December 2024. Her key responsibilities include overseeing clinical trial operations, developing strategic plans, and collaborating with cross-functional teams to ensure study delivery. Notably, she has advanced through various roles within Roche, demonstrating her growth and dedication to the company.
Career Progression
Throughout her career, Nergis has held notable roles such as Clinical Operations Lead, Country Study Manager, and Site Activation Lead at prominent companies including Roche, ICON plc, and PPD. Her career trajectory showcases progressive growth, with a focus on clinical research, operations management, and leadership. Key achievements include successfully managing multiple clinical trials, leading cross-functional teams, and implementing process improvements that enhanced operational efficiency.
Academic Background
Although specific details on her education are not available, it is clear that Nergis Sertel has a strong foundation in her field, given her extensive career spanning over a decade in clinical research and operations management.
Areas of Expertise
Nergis Sertel possesses industry-specific skills in clinical trial management, site activation, and feasibility assessment. Her technical competencies include project management, team leadership, and operational planning. Additionally, she has demonstrated leadership and management capabilities through her roles as Senior Clinical Operations Lead and previous team lead positions.
Professional Impact
While specific projects or initiatives are not detailed, Nergis's progression to senior roles and her long-standing career in the pharmaceutical industry indicate significant contributions to the field. Her ability to manage complex clinical trials and lead teams effectively has likely resulted in measurable achievements in terms of study delivery and operational excellence.
Conclusion
Nergis Sertel's professional trajectory is marked by consistent growth and a strong focus on clinical operations management. Currently, as a Senior Clinical Operations Lead at Roche, she continues to drive operational excellence and contribute to the success of clinical trials. Her value proposition lies in her extensive experience, leadership capabilities, and technical competencies, making her a valuable asset to the pharmaceutical industry.